An Inpatient Advanced Care Practitioner-delivered Advance Care Planning Intervention for Older Patients With Hematologic Malignancies

Overview

This is a pilot study to assess the preliminary efficacy of an inpatient advanced care practitioner (APP)-delivered advance care planning intervention on outcomes in older patients with hematologic malignancies.

SparkCures ID 1485
Trial Phase Pilot Trial
Enrollment 88 Patients
Trial Sponsors
  • University of Rochester
NCT Identifier

NCT05433090

Am I Eligible?

The following criteria is a partial list of reasons why patients may or may not be eligible to participate in this clinical trial. Further evaluation with a medical professional will be required to determine full eligibility.

The following criteria is provided for health care professionals.

Inclusion Criteria:

* Age ≥60 years
* A diagnosis of hematologic malignancy [including but not limited to acute leukemia, myeloid malignancies (e.g., atypical CML, MDS/MPN overlap syndromes, CMML), multiple myeloma, lymphoma, or any other hematologic malignancies based on the primary oncologist's judgment]
* Able to provide informed consent
* Being managed in the inpatient setting
* English-speaking

Exclusion Criteria:

* None

US Trial Locations

Please visit the ClinicalTrials.gov page for historical site information.

View Centers